Home›Companies›Biotech & Pharma›Eldec Pharmaceuticals

Eldec Pharmaceuticals, Inc.

Updated Oct 29, 2026·Latest SEC filing Feb 12, 2026·Suggest an edit

About Eldec Pharmaceuticals

Eldec Pharmaceuticals is a private company based in Chapel Hill, North Carolina. It has reported $200,000 raised in one offering on Form D since February 2026. Its chief executive is Robert Schotzinger.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 11, 2026Feb 12, 2026$200,000of $1.5M target1$200KDebt, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Eldec Pharmaceuticals's Form D filed Feb 12, 2026.

RT
Robert Tarran
Executive officer and director
RS
Robert Schotzinger
CEO and director

Sources

  1. SECEldec Pharmaceuticals, Inc. filing history